Vitiligo Possibly Triggered by COVID-19 Vaccination
Open Access
- 3 January 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e20902
Abstract
Several cutaneous manifestations following COVID-19 vaccination have been cited in the literature since the beginning of the pandemic. Two case reports regarding the development of vitiligo after receiving the COVID-19 vaccine. Herein, we present a case report of a patient who developed new-onset vitiligo two weeks after receiving her COVID-19 vaccine. Although the pathogenesis is unclear, it may be related to the inflammatory cells involved in both the pathogenesis of vitiligo and the mechanism by which the COVID-19 vaccine stimulates the immune system. This case report highlights the need for further investigation into the link between COVID-19 and the development of vitiligo.Keywords
This publication has 6 references indexed in Scilit:
- New‐onset vitiligo following mRNA‐1273 (Moderna) COVID‐19 vaccinationClinical Case Reports, 2021
- Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?Clinical and Experimental Dermatology, 2021
- Purpuric Rash and Thrombocytopenia After the mRNA-1273 (Moderna) COVID-19 VaccineCureus, 2021
- The art of prevention: COVID-19 vaccine preparedness for the dermatologistInternational Journal of Women's Dermatology, 2021
- SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisisRheumatology International, 2021
- The Role of Memory CD8+ T Cells in VitiligoThe Journal of Immunology, 2019